Who cares about patent, just extend them when they expire in a decade. Why would IMU want to sell HER-Vaxx cheaply to raise $50-100M when they only need breathing room for just a quarter??? This CN gives them that option and who knows if IMU release data earlier than expected and the pps re-rate to 10c then you can vote against them end of next month. LC didn't lie about the clinical trial for VAXINIA so I'm trusting her that they are also seeing the clinical trial for OASIS is working as expected just like she said about VAXINIA. If they don't get released in the next 3-6 months then I'll join you in contacting the ASX.
IMU Price at posting:
3.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)